Literature DB >> 862134

Membrane lipids as intracellular binders of chlorpromazine and related drugs.

C D Francesco, M H Bickel.   

Abstract

Equilibrium dialysis studies with chlorpromazine (CPZ) showed affinity and binding capacity values which were not significantly different with the following binders: rat liver microsomes, mitochondria, mitochondrial membranes, brain synaptosomes, myelin vesicles, and red blood cell membranes. There was no binding to cytosol or mitochondrial matrix. The same binding values as above were obtained with protein-free liposomes of lipids extracted from microsomes, mitochondrial and red cell membranes and of pure egg lecithin. The binding values of the two classes of binding sites of all these preparations were K1=2.7+/-1.0-10(4) M-1, K2=3.8+/-1.7-10(3) M-1, C1=580+/-+/-230 and C1+2=1410+/-500 nmole/mg phospholipid. These values were not altered by elimination of the polar head groups of phospholipids with phospholipase C. The results were confirmed by a UV spectroscopic method whereby the strongest binding signals were obtained with CPZ in the presence of fatty acids such as oleate. It is concluded that the major intracellular binders of CPZ and related drugs are the nonpolar moieties of membrane phospholipids, whereby hydrophobic interactions are mainly involved.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 862134     DOI: 10.1016/0009-2797(77)90113-2

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  8 in total

1.  Thermodynamics and mathematical modeling of the partitioning of chlorpromazine between n-octanol and aqueous buffer.

Authors:  S W Cheng; R Shanker; S Lindenbaum
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

2.  Axial tissue diffusion can account for the disparity between current models of hepatic elimination for lipophilic drugs.

Authors:  L P Rivory; M S Roberts; S M Pond
Journal:  J Pharmacokinet Biopharm       Date:  1992-02

3.  A technique for the comparison of biological distribution and solvent partition of drugs.

Authors:  P L Gigon; H van Hees; M H Bickel
Journal:  Experientia       Date:  1983-07-15

4.  Interaction of chlorpromazine with organic solvents and fatty acids as studied by UV-spectrophotometry.

Authors:  M H Bickel; J Römer
Journal:  Experientia       Date:  1978-08-15

5.  Pulmonary accumulation of drugs in vitamin A deficiency.

Authors:  Z H Siddik; M A Trush; T E Gram
Journal:  Lung       Date:  1980       Impact factor: 2.584

6.  Prediction of total propofol clearance based on enzyme activities in microsomes from human kidney and liver.

Authors:  Wael S Al-Jahdari; Koujirou Yamamoto; Haruhiko Hiraoka; Katsunori Nakamura; Fumio Goto; Ryuya Horiuchi
Journal:  Eur J Clin Pharmacol       Date:  2006-06-09       Impact factor: 2.953

7.  Thioridazine as Chemotherapy for Mycobacterium avium Complex Diseases.

Authors:  Devyani Deshpande; Shashikant Srivastava; Sandirai Musuka; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

8.  In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.

Authors:  Jacek Wójcikowski; Przemysław J Danek; Agnieszka Basińska-Ziobroń; Renata Pukło; Władysława A Daniel
Journal:  Pharmacol Rep       Date:  2020-03-26       Impact factor: 3.024

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.